|
Muñoz-Delgado E, Montenegro MF, Morote-García JC, Campoy FJ, Cabezas-Herrera J, Kovacs G, Vidal CJ. The expression of cholinesterases in human renal tumours varies according to their histological types. Chem Biol Interact. 2008 Sep 25;175(1-3):340-2. doi: 10.1016/j.cbi.2008.04.003. Epub 2008 Apr 12. PubMed PMID: 18482720.
AÑO: 2008; IF: 3.077
|
18482720
|
Navarro-Perán E, Cabezas-Herrera J, Sánchez-Del-Campo L, García-Cánovas F, Rodríguez-López JN. The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-kappaB suppression. Inflamm Res. 2008 Oct;57(10):472-8. doi: 10.1007/s00011-008-8013-x. PubMed PMID: 18830563.
AÑO: 2008; IF: 1.457
|
|
Martínez-López de Castro A, Nieto-Cerón S, Aurelio PC, Galbis-Martínez L, Latour-Pérez J, Torres-Lanzas J, Tovar-Zapata I, Martínez-Hernández P, Rodríguez-López JN, Cabezas-Herrera J. Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Clin Sci (Lond). 2008 Oct;115(8):245-53. doi: 10.1042/CS20070393. PubMed PMID: 18211261.
AÑO: 2008; IF: 4.187
|
|
Navarro-Perán E, Cabezas-Herrera J, Campo LS, Rodríguez-López JN. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int J Biochem Cell Biol. 2007;39(12):2215-25. Epub 2007 Jun 26. PubMed PMID: 17683969.
AÑO: 2007; IF: 4.009
|
|
Rodríguez-Manotas M, Amorín-Díaz M, Cañizares-Hernández F, Ruíz-Espejo F, Martínez-Vidal S, González-Sarmiento R, Martínez-Hernández P, Cabezas-Herrera J. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism. Brain Res. 2007 Sep 19;1170:119-28. Epub 2007 Jul 25. PubMed PMID: 17719017.
AÑO: 2007; IF: 2.218
|